Provided by Tiger Trade Technology Pte. Ltd.

NASDAQ Biotechnology

5,979.49
-31.1286-0.52%
High:6,003.60
Open:5,968.10
Low:5,926.30
Close:6,010.62
52wk High:6,055.17
52wk Low:3,568.35

Loading ...

Press Release: National Bank Investments Announces January 2026 Cash Distributions for NBI ETFs and NBI Funds ETF Series

Dow Jones
·
Jan 16

Press Release: National Bank Investments Announces Revised 2025 Annual Reinvested Distribution Amounts for NBI ETFs and NBI Funds ETF Series

Dow Jones
·
Jan 05

Upstream Bio (UPB): Reassessing Valuation After NASDAQ Biotechnology Index Inclusion and Sharp 3‑Month Rally

Simply Wall St.
·
Dec 23, 2025

Press Release: National Bank Investments Announces December 2025 Cash Distributions for NBI ETFs and NBI Funds ETF Series

Dow Jones
·
Dec 18, 2025

Neurocrine Biosciences (NBIX) valuation update after NBI-1070770 Phase 2 trial failure reshapes pipeline expectations

Simply Wall St.
·
Dec 07, 2025

Press Release: National Bank Investments Announces November 2025 Cash Distributions for NBI ETFs and NBI Funds ETF Series

Dow Jones
·
Nov 14, 2025

Neurocrine says Phase 2 study of NBI-1070770 did not meet primary endpoint

TIPRANKS
·
Nov 11, 2025

Neurocrine Biosciences Completes Phase 2 Study on NBI-1070770 for Depression

TIPRANKS
·
Oct 30, 2025

Press Release: National Bank Investments Announces October 2025 Cash Distributions for NBI ETFs and NBI Funds ETF Series

Dow Jones
·
Oct 17, 2025

NIRAKU (01245): NBI Plans to Acquire Land and Buildings in Atami, Shizuoka Prefecture for 791 Million JPY

Stock News
·
Oct 16, 2025

Press Release: National Bank Investments Announces September 2025 Cash Distributions for NBI ETFs and NBI Funds ETF Series

Dow Jones
·
Sep 15, 2025

Press Release: National Bank Investments Announces August 2025 Cash Distributions for NBI ETFs and NBI Funds ETF Series

Dow Jones
·
Aug 15, 2025